Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Pacira Pharmaceuticals Inc announces FDA approval of additional manufacturing suite for EXPAREL

Monday, 31 Mar 2014 06:30am EDT 

Pacira Pharmaceuticals Inc:Receives FDA approval for additional bulk manufacturing suite, referred to as Suite C, for EXPAREL.Suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured. 

Company Quote

6 Jul 2015